BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9684575)

  • 1. Role of cytology in the intraoperative diagnosis of central demyelinating disease.
    Raisanen J; Goodman HS; Ghougassian DF; Harper CG
    Acta Cytol; 1998; 42(4):907-12. PubMed ID: 9684575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cortical demyelination in PML and MS: similarities and differences.
    Savolainen H
    Neurology; 2009 Mar; 72(9):861. PubMed ID: 19255419
    [No Abstract]   [Full Text] [Related]  

  • 3. Occurrence of oligodendrocytes within astrocytes in demyelinating lesions.
    Ghatak NR
    J Neuropathol Exp Neurol; 1992 Jan; 51(1):40-6. PubMed ID: 1740673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progressive multifocal leukoencephalopathy: a review of the neuroimaging features and differential diagnosis.
    Sahraian MA; Radue EW; Eshaghi A; Besliu S; Minagar A
    Eur J Neurol; 2012 Aug; 19(8):1060-9. PubMed ID: 22136455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A giant MS plaque mimicking PML during natalizumab treatment.
    Twyman C; Berger JR
    J Neurol Sci; 2010 Apr; 291(1-2):110-3. PubMed ID: 20144466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytomorphology of progressive multifocal leukoencephalopathy (PML): review of sixteen cases occurring in HIV-positive patients.
    Yu GH; Hidvegi DF; Cajulis RS; Brody BA; Levy RM
    Diagn Cytopathol; 1996 Feb; 14(1):4-9. PubMed ID: 8834069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Progressive multifocal leukoencephalopathy. Study of the demyelination by magnetization transfer].
    Armand JP; Dousset V; Franconi JM; Huot P; Mièze S; Lacoste D; Letenneur L; Caillé JM
    J Radiol; 1997 Feb; 78(2):131-4. PubMed ID: 9113157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive multifocal leukoencephalopathy and relapsing-remitting multiple sclerosis: a comparative study.
    Boster A; Hreha S; Berger JR; Bao F; Penmesta R; Tselis A; Endress C; Zak I; Perumal J; Caon C; Vazquez J; Tyler KL; Racke MK; Millis S; Khan O
    Arch Neurol; 2009 May; 66(5):593-9. PubMed ID: 19433659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple malignant astrocytomas in a patient with spontaneous progressive multifocal leukoencephalopathy.
    Sima AA; Finkelstein SD; McLachlan DR
    Ann Neurol; 1983 Aug; 14(2):183-8. PubMed ID: 6625535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anaplastic astrocytoma mimicking progressive multifocal leucoencephalopathy: a case report and review of the overlapping syndromes.
    Kantorová E; Bittšanský M; Sivák Š; Baranovičová E; Hnilicová P; Nosáľ V; Čierny D; Zeleňák K; Brück W; Kurča E
    BMC Cancer; 2017 Jun; 17(1):424. PubMed ID: 28629398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formalin fixed brains are useful for magnetic resonance imaging (MRI) study.
    Nagara H; Inoue T; Koga T; Kitaguchi T; Tateishi J; Goto I
    J Neurol Sci; 1987 Oct; 81(1):67-77. PubMed ID: 3681342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Filamentous and multilamellated cytoplasmic inclusions in progressive multifocal leukoencephalopathy.
    Hauw JJ; Esourolle R
    Acta Neuropathol; 1977 Mar; 37(3):263-5. PubMed ID: 193344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The chameleon of neuroinflammation: magnetic resonance imaging characteristics of natalizumab-associated progressive multifocal leukoencephalopathy.
    Wattjes MP; Richert ND; Killestein J; de Vos M; Sanchez E; Snaebjornsson P; Cadavid D; Barkhof F
    Mult Scler; 2013 Dec; 19(14):1826-40. PubMed ID: 24192217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Common and uncommon imaging findings in progressive multifocal leukoencephalopathy (PML) with differential diagnostic considerations.
    Horger M; Beschorner R; Beck R; Nägele T; Schulze M; Ernemann U; Heckl S
    Clin Neurol Neurosurg; 2012 Oct; 114(8):1123-30. PubMed ID: 22771304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Atypical progressive multifocal leukoencephalopathy (PML) in a patient with pulmonary sarcoidosis].
    Le Guilloux J; Roubiou C; Mallet J; Bouvry D; Alkhalil A; Coman I; Belin C; Gorochov G; Carpentier A; Mokhtari K; Carpentier AF
    Rev Neurol (Paris); 2010 Mar; 166(3):341-5. PubMed ID: 19589551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asymptomatic Progressive Multifocal Leukoencephalopathy Associated with Natalizumab: Diagnostic Precision with MR Imaging.
    Hodel J; Outteryck O; Dubron C; Dutouquet B; Benadjaoud MA; Duhin E; Verclytte S; Zins M; Luciani A; Rahmouni A; Pruvo JP; Vermersch P; Leclerc X
    Radiology; 2016 Mar; 278(3):863-72. PubMed ID: 26436861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of MRI appearances due to progressive multifocal leucoencephalopathy following natalizumab treatment for multiple sclerosis.
    Campbell S; Kanodia AK; O'Riordan J
    BMJ Case Rep; 2015 Apr; 2015():. PubMed ID: 25878241
    [No Abstract]   [Full Text] [Related]  

  • 18. [Targeted therapy and progressive multifocal leukoencephalopathy (PML): PML in the era of monoclonal antibody therapies].
    Takao M
    Brain Nerve; 2013 Nov; 65(11):1363-74. PubMed ID: 24200614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of cytology in the intraoperative diagnosis of HIV-positive patients undergoing stereotactic brain biopsy.
    Cajulis RS; Hayden R; Frias-Hidvegi D; Brody BA; Yu GH; Levy R
    Acta Cytol; 1997; 41(2):481-6. PubMed ID: 9100784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lessons learned from fatal progressive multifocal leukoencephalopathy in a patient with multiple sclerosis treated with natalizumab.
    Boster AL; Nicholas JA; Topalli I; Kisanuki YY; Pei W; Morgan-Followell B; Kirsch CF; Racke MK; Pitt D
    JAMA Neurol; 2013 Mar; 70(3):398-402. PubMed ID: 23338729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.